Malignant rhabdoid tumors (MRTs) are rare, pediatric soft-tissue tumors. Homozygous deletions at chromosome 22q11.2 are a recurrent cytogenetic characteristic of MRTs, an indication that this locus may harbor one or more genes conferring tumorsuppressor activity. We constructed a deletion map of the relevant part of 22q11.2 from a panel of seven MRT cell lines, and isolated a novel gene from the center of the region. As it showed a high degree of sequence homology to genes of the Rab family, we designated it Rab36. The protein encoded by Rab36 was localized at the Golgi body. Sequencing of Rab36 cDNAs from three cell lines that retained at least one allele of this gene revealed no nonsense or frameshift mutations. Experiments to induce over-expression of Rab36 by transfection to an MRT cell line similarly failed to justify designation of this gene as a tumor suppressor that would contribute to tumorigenesis by a loss-offunction mechanism. © 1999 Academic Press Key Words: malignant rhabdoid tumor; homozygous deletion; chromosome 22; Rab.
Malignant rhabdoid tumors (MRTs) are rare neoplasms of childhood that occur primarily within the first three years of life. They may arise in various locations including the central nervous system and kidney, and extend aggressively thereafter. As deletions and translocations involving chromosome band 22q11-12 are recurrent cytogenetic characteristics of MRTs, this region is thought to harbor one or more tumor suppressor genes that are inactivated in this type of tumor (1) (2) (3) (4) (5) (6) . Studies designed to narrow the region have mapped the putative locus by fluorescence in situ hybridization (FISH) to a genomic segment of about 500 kb between the immunoglobulin lambda gene (IGL) and the BCR loci at 22q11.2 (7) . To begin a search for putative tumor suppressor genes within this region, we undertook shotgun-sequencing of an 80-kb stretch of genomic DNA containing two sequence tagged-sites (STSs), GNAZ and BCR5Ј, that lie halfway between IGL and BCR.
Here we report the isolation and characterization of a novel gene in this region. The cDNA showed a high degree of sequence homology to genes of the Rab family, and was designated Rab36. To investigate the possible involvement of Rab36 in cell growth and proliferation, we introduced a Rab36 expression vector into a Rab36-deficient MRT cell line. Additionally, we determined the sub-cellular localization of the gene product by introducing the Rab36 expression vector into Cos-7 cells.
MATERIALS AND METHODS
MRT cell lines. Seven MRT cell lines were established from primary rhabdoid tumors. The clinicopathological characteristics of four of them, TM87-16 (8, 9) , STM91-01 (9) , and TTC549 and TTC642 (7), had already been reported. The other three cell lines (KP-MRT-HS, KP-MRT-NS and MP-MRT-AN) were newly established. All MRT cells were cultured in RPMI1640 medium supplemented with 10% fetal calf serum and antibiotic/antimycotic solution (Sigma, St. Louis, MO, USA). Cos-7 cells were cultured in DMEM containing 10% fetal calf serum and antibiotic/antimycotic solution (Sigma).
Construction of a contig and mapping of the homozygous deletion.
A high-resolution YAC contig map of 22q had been constructed previously (10) . The nucleotide sequence of YAC267D3, which spans the entire genomic insert containing GNAZ and BCR5Ј, was obtained from the Whitehead Institute data base (http://www-seq.wi.mit.edu/ publicϪrelease/) and confirmed by the PCR. We constructed a contig of cosmids from this YAC, in the manner described previously (11) .
Southern-blot hybridization. Each genomic DNA (10 g) was completely digested with EcoRI, electrophoresed on a 0.8% agarose gel, and blotted to a nylon membrane (Biodyne B, Pall, NY, USA). Cosmid DNA probes were labeled with [␣] 32 P by random-primer extension using a random-primer labeling kit (Megaprime, AmerBiochemical and Biophysical Research Communications 254, 594 -600 (1999) Article ID bbrc.1998.9968, available online at http://www.idealibrary.com on sham Pharmacia Biotech AB, Uppsala, Sweden) according to the manufacturer's instructions. Each membrane was hybridized overnight with one of the radioactive probes at 65°C in a solution containing 10% SDS, 7% polyethylene glycol 8000, and 200g/ml of denatured human-placenta DNA. After hybridization, the membranes were washed twice at room temperature (RT) in 2ϫ standard saline citrate (SSC) and twice at 65°C in 0.1ϫ SSC and 0.1% SDS for 15 min each, then exposed to Kodak X-Omat films (Eastman Kodak Company, Rochester, NY, USA) at Ϫ80°C for 1-2 days. Cosmid probes were selected by screening a human cosmid library by colony hybridization with STSs for D22S556 and 765E3L. The GNAZ and BCR5Ј loci were both contained in the cosmid contig derived from YAC 267D3 (Fig. 1) .
DNA sequencing and isolation of the cDNA. Two cosmid clones, one containing GNAZ and the other BCR5Ј, were completely sequenced using the shotgun method detailed previously (12) . We analyzed genomic DNA sequences from the target region with an exon-prediction computer program (GRAIL2) and performed exonconnection experiments by reverse-transcriptase PCR (RT-PCR) to investigate whether the predicted candidate-exons were actually transcribed. RT-PCR was performed as described previously (12) . We subjected the connected cDNA fragment to 5Ј and 3Ј rapid amplification of cDNA ends (RACE) using testis mRNA as a template and the Marathon cDNA amplification kit (Clontech Laboratories, Palo Alto, CA, USA), according to the manufacturer's instructions. Finally, the full-length cDNA was identified by the oligo-capping method, using oligo-capped thymus mRNA provided by Dr. Sumio Sugano (13) .
Northern-blot hybridization. Nylon membranes blotted with poly(A) RNA from various human tissues were purchased from Clontech. The probe, a 300-bp DNA fragment carrying coding sequences of Rab36, was labeled with [␣] 32 P using a random-primer labeling kit (Megaprime, Amersham Pharmacia Biotech AB) according to the manufacturer's instructions. The blots were hybridized with the radioactive probe at 42°C overnight, washed with 0.1ϫ SSC/ 0.1% SDS at 50°C, and exposed for 1 week to Kodak X-Omat film (Eastman Kodak Company) at Ϫ80°C.
RT-PCR of Rab36.
Total RNA from each MRT cell line was isolated using TRIZOL regent (Gibco BRL, Gaithersburg, MD, USA), and cDNAs were prepared using random-primer oligonucleotides. Approximately 5 g of RNA in a final volume of 11 l was first denatured at 70°C for 10 min and then cooled on ice. For first-strand DNA synthesis, 1 l (200 U) of Superscript II Reverse Transcriptase (Gibco BRL), 200 mM DTT, 40 pM random primers (Boehinger Mannheim, Mannheim, Germany), 10 mM deoxynucleotide triphosphate, and 40 units of RNase block were added to a final volume of 20 l in an appropriate RT buffer. The Rab36-specific primers used for PCR amplification were Rab36-S (5Ј-TTTCACAGCCATCGCTGGAC-3Ј) and Rab36-AS (5Ј-AGTCTCCGCACCACAGTGAC-3Ј); the Rab36-specific product size corresponded to 915bp. Primers specific for amplification of the housekeeping beta-actin gene were ACTIN-S (5Ј-CAAGAGATGGCCACGGCTGC-3Ј) and ACTIN-AS (5Ј-CCTTCT-GCATCCTGTCGGCA-3Ј). PCR amplification was performed at 94°C for 1 min, 60°C for 1 min, and 72°C for 1 min, for 30 cycles (Rab36) or 20-25 cycles (␤-actin).
Construction of expression vector (myc-tagged Rab36
). Plasmids designed to express Rab36 were constructed by cloning the entire coding region of Rab36 cDNA into the pcDNA3.1 expression vector (Invitrogen, San Diego, CA, USA), which carries a CMV promoter and a gene conferring neomycin resistance. To add a myc-epitope tag (EQKLISEEDL) at the N-terminal of the protein, oligonucleotide duplexes encoding Kozak and myc-epitope sequences were inserted into the HindIII-EcoRI multi-cloning site of the vector. Then the entire coding sequence of Rab36 cDNA generated by PCR was ligated in-frame between the EcoRI and XhoI sites of the expression vector. The constructs were confirmed by sequencing.
Transfection of the expression vectors. Cos-7 cells (1 ϫ 10 5 ) were plated in 3.5-cm culture dishes 24 hours before transfection. Expression vectors (2g per dish) were transfected using 15 l Trans IT-LT1(Pan Vera Corporation, Madison, WI, USA) according to the manufacturer's instructions. 24 hours after transfection, the cells were either harvested for preparing cell extracts, re-plated on plates of another size, or mounted on chamber slides.
Antibodies, immunoblotting, and immunocytochemistry. Myc tag-specific monoclonal antibody 9E10 was purchased from PharMingen (San Diego, CA, USA). For immunoblotting, transiently transfected cells were lysed in SDS-sample buffer and the extracts were resolved by electrophoresis on 10% SDS-polyacrylamide gels (SDS-PAGE) and transferred to PVDF membrane (Fluorotrans, Pall). Primary antibodies were diluted in blocking solution (for antimyc antibodies: 3% BSA in PBS) and incubated with the membrane for 1 hour at RT. Labeled bands were visualized with enhanced chemiluminescence (Amersham Pharmacia Biotech AB).
For immunocytochemical analysis, transiently transfected Cos-7 cells replated on poly-D-lysine-coated multi-well chamber slides (Biocoat, Becton Dickenson Labware, Bedford, MA, USA) were washed with PBS containing 1 mM CaCl 2 and 0.5 mM MgCl 2 , fixed with PBS containing 4% paraformaldehyde, and rendered permeable with PBS containing 0.1% Triton X-100 for 3 min at 4°C. Cells were covered with blocking solution (3% BSA in PBS) for 30 min at RT to block sites subject to non-specific binding of antibody. Then the cells were incubated for 30 min at RT with anti-myc polyclonal antibodies purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) (diluted 1:800 in blocking solution) and a rabbit anti-Golgi antibody(Sigma) (diluted 1:800 in blocking solution). Antibodies were stained with a goat anti-mouse secondary antibody conjugated with rhodamine (Leinco Technologies, St. Louis, MO, USA) and a goat anti-rabbit secondary antibody conjugated to FITC(ICN Pharmaceuticals, Inc., Aurora, OH, USA), and viewed with an ECLIPSE E800 microscope (Nikon, Tokyo, Japan).
Colony-formation assay. STM91-01 cells were plated in T25 flasks (2 ϫ 10 5 cells/flask) and transfected 24 hours later with Rab36 expression vector (pcDNA3.1/Rab36 S) containing the sense strand of the Rab36 cDNA. As controls, we transfected the same cell line with the plasmid (pcDNA3.1/Rab36 AS) that carried Rab36 cDNA in anti-sense configuration. Six micrograms of plasmid DNAs and 25g of Trans IT-LT1 were used for each transfection. Cells were diluted 1:9 after 12 hours of transfection, re-plated in 3.5-cm culture dishes, and cultured for 14 days in the presence of 1.0 mg/ml of G418 (Geneticin, Gibco BRL).
RESULTS

Physical Contig of the MRT Critical Region
To map in detail the homozygous deletions of chromosome band 22q11.2 that are often seen in MRTs, we amplified multiple loci at 22q11.2 using PCR. First we tested 18 loci in DNA from the KP-MRT-HS cell line. For nine of the markers, no specific PCR products were obtained, suggesting that the loci defined by those markers lay within the homozygous deletion. The same markers were tested in DNA from the other six cell lines, and a refined deletion map was constructed on the basis of the results.
YAC267D3 contains four STSs, namely D22S303, GNAZ, BCR5Ј and D22S257, according to the Whitehead database. A pulsed-field electrophoretic analysis of this YAC indicated that it spans about 300 kb of genomic DNA (data not shown). We constructed a cos-mid contig covering YAC267D3 (Fig. 1A) . To confirm the PCR results we performed Southern-blot hybridization using DNAs from all seven MRT cell lines with four of the cosmids (a-d) as probes. The results clearly indicated a complete absence of the expected genomic DNA fragments in four of the cell lines (KP-MRT-HS, STM91-01, MP-MRT-AN and TTC549) (Fig. 1B) .
Molecular Cloning of Rab36
Computer analysis of the DNA sequences in the 80-kb region covered by the cosmids containing GNAZ and BCR5Ј (Fig. 1A, b and c) predicted four possible exons with "excellent" scores in addition to the known exons contained in GNAZ and BCR.
Exon-connection experiments performed to determine whether the exon-candidates were transcribed in human tissues indicated that all four belonged to the same coding element. RT-PCR experiments and subsequent cDNA 5Ј and 3Ј RACE yielded a novel gene spanning approximately 19 kb of genomic DNA and consisting of 11 exons, 3,823 nucleotides, and an open reading frame of 1,002 bp. A homology search using the FASTA program (GenomeNet) revealed that the gene product belonged to the Rab family of proteins, and we designated it Rab36. Several motifs present in the Rab family were identified within the predicted amino acid sequence of Rab36 (Fig. 2A) ; three phosphate/Mg 2ϩ -binding motifs are present, as well as three guaninebinding motifs, a tyrosine kinase phosphorylation site (KXXXDXXY), and a C-terminal isoprenylation signal (CC) (14) . A comparison of Rab36 sequence with the highly conserved regions of related proteins is shown in Fig. 2B .
Northern-Blot Analysis
Northern-blot analysis of Rab36 revealed 4.0 kb and 2.2 kb mRNAs in all human tissues examined (Fig.   FIG. 1 3A). The result of 3Ј RACE revealed that the larger transcript contained a longer 3Ј non-coding sequence.
RT-PCR of Rab36
RT-PCR analysis showed that Rab36 mRNA was expressed in KP-MRT-NS, TM87-16, and TTC642; in fact, it was over-expressed in TM87-16 and TTC642 (Fig. 3B) . Direct sequencing of cDNAs from these three cell lines showed neither nonsense nor frameshift mutations (data not shown).
Localization of Rab36 in Mammalian Cells by Immunocytochemistry
To examine the sub-cellular localization of Rab36 we introduced a Rab36 expression vector into Cos-7 cells and detected the gene product by immunocytochemistry. First we confirmed expression of Rab36 in the transfected cells by immunoblotting. As shown in Fig.  4A , the protein was expressed and specifically recognized by anti-myc tag antibodies at a molecular size of 36 kD. Immunofluorescent analysis revealed that Rab36 was localized at the Golgi body (Fig. 4B) . This result strongly suggests that Rab36, like some other Rab family proteins (14) , is concerned with vesicular transport around the Golgi apparatus.
Colony-Formation Assay
A colony-formation assay was carried out to investigate whether Rab36 may play an important role in the genesis of malignant rhabdoid tumors. As shown in Fig. 5 , the number of neomycin-resistant colonies transfected with sense-strand cDNA was equivalent to the number of colonies transfected with anti-sense cDNA. This experiment was repeated three times independently with the same result. Therefore Rab36 does not appear to be concerned with either cell proliferation or cell death.
DISCUSSION
The long arm of chromosome 22 is frequently involved in translocations or deletions in MRTs, and this fact has implied the presence of one or more tumor suppressor genes mapping to 22q11. 2 (1-7) . However, the critical region defined by cytogenetic analyses was too wide to identify any candidate genes. We constructed a homozygous-deletion map of part of 22q11.2 from a panel of seven MRT cell lines, three of them newly established, to estimate a minimally deleted region. We found it to be, at most, 6 cM long, spanning two STSs (D22S556 and D22S345); however, the common region was longer in physical terms than previously reported (10) . We performed shotgun sequencing of 80 kb of genomic DNA at the center of this region, because a previous study had suggested that the region commonly deleted in MRTs lay between IGL and BCR, which are less than 500 kb apart (7). Our sequencing of this "MRT critical region" revealed that a novel Rabfamily gene, Rab36, was present there. However, direct sequencing of cDNAs from the three cell lines (KP-MRT-NS, TM87-16, and TTC642) that retained at least one allele indicated that none had undergone either nonsense or frameshift mutations of Rab36.
The protein encoded by Rab36 is 36 kD (Fig. 4A ), larger than some other members of the Rab family. In amino-acid sequence Rab36 bears the closest homology to murine Rah (15), human Rab13 (16), murine Rab23 (17) , and the other Rab proteins indicated in Fig. 3B  (18,19) . Rab molecules are often involved in regulating membrane traffic along biosynthetic and endocytic pathways in eukaryotic cells. In mammalian cells, more than 40 members of this family have been identified (14) . Evidence is increasing that many Rab proteins are localized in intracellular compartments along endocytic and the exocytic pathways; however, their exact functions have not yet been clarified. In the present study, transient over-expression of Rab36 showed its sub-cellular localization at the Golgi body. To our knowledge no known Rab-family protein is known to function as a tumor suppressor. Indeed, the results of our colony-formation assay with a Rab36-deficient MRT cell line, STM91-01, indicated no differ- growth, differentiation, or apoptoic processes. However, no additional reports have corroborated the suggestion that SNF/SWI complexes exert tumor suppressing activity.
Even though we isolated Rab36 from within the "MRT critical region", our results did not support a designation of this novel gene as a tumor suppressor of MRTs. Its actual function remains unclear. However, on the basis of sequence homology and sub-cellular localization, we suggest that Rab36 may, like Rab6, contribute to vesicular trafficking associated with intra-Golgi transport (14, 19, 22) .
